Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • EGrassi
    Member
    • Oct 2010
    • 66

    Tophat 2.0.0 strange errors

    Hello, I've been running some test with fake data with tophat (in order to compare results from different tools like cufflink/cuffdiff/deseq/MISO/...) and I've stumbled in a strange error.
    Code:
            
    $tophat -p 5 -G /rogue/bioinfotree/prj/rnaseq_test/local/share/data/fake.gtf --transcriptome-index=transcriptome -o S1_001.th ../alignment/expanded_genome2 <(zcat /rogue/bioinfotree/prj/rnaseq_test/dataset/0.1/reads//S1_blah_R1_001.fastq.gz) <(zcat /rogue/bioinfotree/prj/rnaseq_test/dataset/0.1/reads//S1_blah_R2_001.fastq.gz)
    
    [2012-09-04 14:12:39] Beginning TopHat run (v2.0.0)
    -----------------------------------------------
    [2012-09-04 14:12:39] Checking for Bowtie
                      Bowtie version:        2.0.0.6
    [2012-09-04 14:12:39] Checking for Samtools
                    Samtools version:        0.1.18.0
    [2012-09-04 14:12:39] Checking for Bowtie index files
    [2012-09-04 14:12:39] Checking for reference FASTA file
    [2012-09-04 14:12:39] Generating SAM header for ../alignment/expanded_genome2
            format:          fastq
            quality scale:   phred33 (default)
    [2012-09-04 14:13:09] Reading known junctions from GTF file
    [2012-09-04 14:13:09] Preparing reads
            [FAILED]
    Error retrieving prep_reads info.
    make: *** [S1_001.th] Error 1
    In the logs I see:
    Code:
    cat S1_001.th/logs/prep_reads.log 
    prep_reads v2.0.0 (3280)
    ---------------------------
    0 out of 0 reads have been filtered out
    But if I manually launch prep_reads getting the command line from run.log it seems to run without any problem:
    Code:
    /home/data/rnaseq/bin/prep_reads --min-anchor 8 --splice-mismatches 0 --min-report-intron 50 --max-report-intron 500000 --min-isoform-fraction 0.15 --output-dir S1_001.th/ --max-multihits 20 --max-seg-multihits 40 --segment-length 25 --segment-mismatches 2 --min-closure-exon 100 --min-closure-intron 50 --max-closure-intron 5000 --min-coverage-intron 50 --max-coverage-intron 20000 --min-segment-intron 50 --max-segment-intron 500000 --max-mismatches 2 --max-insertion-length 3 --max-deletion-length 3 -z gzip -p5 --inner-dist-mean 50 --inner-dist-std-dev 20 --gtf-annotations transcriptome/fake.gff --gtf-juncs S1_001.th/tmp/fake.juncs --no-closure-search --no-coverage-search --no-microexon-search --fastq --aux-outfile=S1_001.th/left_kept_reads.info --index-outfile=S1_001.th/tmp/left_kept_reads.bam.index --sam-header=S1_001.th/tmp/expanded_genome2.bwt.samheader.sam --outfile=S1_001.th/tmp/left_kept_reads.bam <(zcat /rogue/bioinfotree/prj/rnaseq_test/dataset/0.1/reads//S1_blah_R1_001.fastq.gz)
    prep_reads v2.0.0 (3280)
    ---------------------------
    0 out of 3 reads have been filtered out
    Any idea? Thanks.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Working...